Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

y3maxx

Send PM Follow Ignore
Followers 3
Posts 1781
Boards Moderated 0
Alias Born 07/06/2004

y3maxx

Re: indigokid post# 8083

Wednesday, 01/04/2012 1:02:05 PM

Wednesday, January 04, 2012 1:02:05 PM

Post# of 20689
""despite the launch of Gilenya, an oral treatment made by Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ), in late 2010""

...Perhaps NVS cares very little of M copax success because of Gilenya?

...Who really knows just how supportive NVS is with M copax at the FDA?

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote